Patent | Date |
---|
Bromodomain Inhibitors App 20210236508 - Wang; Le ;   et al. | 2021-08-05 |
Tetracyclic Bromodomain Inhibitors App 20210070756 - Fidanze; Steven D. ;   et al. | 2021-03-11 |
Tetracyclic Bromodomain Inhibitors App 20200291027 - Fidanze; Steven D. ;   et al. | 2020-09-17 |
Tetracyclic Bromodomain Inhibitors App 20190389861 - Fidanze; Steven D. ;   et al. | 2019-12-26 |
Bromodomain Inhibitors App 20180296566 - Wang; Le ;   et al. | 2018-10-18 |
Tetracyclic Bromodomain Inhibitors App 20180298003 - Fidanze; Steven D. ;   et al. | 2018-10-18 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20180251426 - Bruncko; Milan ;   et al. | 2018-09-06 |
Substituted 1,4,10-triazadibenzo[cd,f]azulenes, substituted 1,4,5,10-tetraazadibenzo[cd,f]azulenes and substituted 1,4,5,7,10-pentaazadibenzo[cd,f]azulenes as bromodomain inhibitors Grant 10,035,800 - Fidanze , et al. July 31, 2 | 2018-07-31 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20160304451 - Elmore; Steven W. ;   et al. | 2016-10-20 |
Dihydro-pyrrolopyridinone Inhibitors App 20160237084 - Wang; Le ;   et al. | 2016-08-18 |
Bromodomain Inhibitors App 20160143916 - Wang; Le ;   et al. | 2016-05-26 |
Dihydro-pyrrolopyridinone inhibitors Grant 9,321,764 - Wang , et al. April 26, 2 | 2016-04-26 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,303,025 - Bruncko , et al. April 5, 2 | 2016-04-05 |
Bromodomain inhibitors Grant 9,296,741 - Wang , et al. March 29, 2 | 2016-03-29 |
Tetracyclic Bromodomain Inhibitors App 20160039821 - Fidanze; Steven D. ;   et al. | 2016-02-11 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,174,982 - Bruncko , et al. November 3, 2 | 2015-11-03 |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,125,913 - Bruncko , et al. September 8, 2 | 2015-09-08 |
BCL-2 selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,073,855 - Doherty , et al. July 7, 2 | 2015-07-07 |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,072,748 - Bruncko , et al. July 7, 2 | 2015-07-07 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20150183775 - BRUNCKO; Milan ;   et al. | 2015-07-02 |
Imidazopyridines as a novel scaffold for multi-targeted kinase inhibition Grant 9,051,315 - Ba-maung , et al. June 9, 2 | 2015-06-09 |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 9,045,420 - Doherty , et al. June 2, 2 | 2015-06-02 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 9,029,404 - Doherty , et al. May 12, 2 | 2015-05-12 |
Dihydro-pyrrolopyridinone Inhibitors App 20140275026 - Wang; Le ;   et al. | 2014-09-18 |
Bromodomain Inhibitors App 20140162971 - WANG; Le ;   et al. | 2014-06-12 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140113910 - Bruncko; Milan ;   et al. | 2014-04-24 |
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140107119 - Bruncko; Milan ;   et al. | 2014-04-17 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140094471 - Bruncko; Milan ;   et al. | 2014-04-03 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140088106 - Bruncko; Milan ;   et al. | 2014-03-27 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20140066621 - Bruncko; Milan ;   et al. | 2014-03-06 |
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057890 - Bruncko; Milan ;   et al. | 2014-02-27 |
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20140057889 - Bruncko; Milan ;   et al. | 2014-02-27 |
BCL-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,586,754 - Bruncko , et al. November 19, 2 | 2013-11-19 |
Bcl-2 Selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20130296295 - BRUNCKO; Milan ;   et al. | 2013-11-07 |
Bcl-2-selective apoptosis-inducing agents for the treatment of cancer and immune diseases Grant 8,563,735 - Bruncko , et al. October 22, 2 | 2013-10-22 |
Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases Grant 8,557,983 - Doherty , et al. October 15, 2 | 2013-10-15 |
Pyrimidine inhibitors of kinase activity Grant 8,536,180 - Clark , et al. September 17, 2 | 2013-09-17 |
Pyrimidine inhibitors of kinase activity Grant 8,486,933 - Wang , et al. July 16, 2 | 2013-07-16 |
Pyrimidine inhibitors of kinase activity Grant 8,354,422 - Clark , et al. January 15, 2 | 2013-01-15 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20120190688 - Bruncko; Milan ;   et al. | 2012-07-26 |
Protein kinase inhibitors Grant 8,067,409 - Ba-Maung , et al. November 29, 2 | 2011-11-29 |
Imidazopyridines As A Novel Scaffold For Multi-targeted Kinase Inhibition App 20110124632 - Ba-maung; Nwe Y. ;   et al. | 2011-05-26 |
Apoptosis Inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100305122 - Bruncko; Milan ;   et al. | 2010-12-02 |
Pyrimidine Inhibitors Of Kinase Activity App 20100305112 - Wang; Gary T. ;   et al. | 2010-12-02 |
Pyrimidine Inhibitors of Kinase Activity App 20100305126 - Clark; Richard F. ;   et al. | 2010-12-02 |
Pyrimidine Inhibitors Of Kinase Activity App 20100305118 - Clark; Richard F. ;   et al. | 2010-12-02 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100298323 - Bruncko; Milan ;   et al. | 2010-11-25 |
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100298321 - Bruncko; Milan ;   et al. | 2010-11-25 |
Substituted pyrazolo[3,4-d]pyrimidines as protein kinase inhibitors Grant 7,772,231 - Sheppard , et al. August 10, 2 | 2010-08-10 |
Apoptosis-inducing Agents For The Treatment Of Cancer And Immune And Autoimmune Diseases App 20100160322 - Bruncko; Milan ;   et al. | 2010-06-24 |
Bcl-2-selective Apoptosis-inducing Agents For The Treatment Of Cancer And Immune Diseases App 20100152183 - Bruncko; Milan ;   et al. | 2010-06-17 |
Protein Kinase Inhibitors App 20090253723 - Ba-Maung; Nwe Y. ;   et al. | 2009-10-08 |
Sulfonamides having antiangiogenic and anticancer activity Grant 7,491,718 - Comess , et al. February 17, 2 | 2009-02-17 |
Farnesyltransferase inhibitors Grant 7,323,570 - Claiborne , et al. January 29, 2 | 2008-01-29 |
Protein Kinase Inhibitors App 20070203143 - Sheppard; George S. ;   et al. | 2007-08-30 |
Farnesyltransferase inhibitors Grant 7,211,595 - Claiborne , et al. May 1, 2 | 2007-05-01 |
Farnesyltransferase Inhibitors App 20060264476 - Claiborne; Akiyo K. ;   et al. | 2006-11-23 |
Urea kinase inhibitors Grant 7,056,925 - Li , et al. June 6, 2 | 2006-06-06 |
Urea kinase inhibitors App 20040259885 - Li, Gaoquan ;   et al. | 2004-12-23 |
Sulfonamides having antiangiogenic and anticancer activity App 20040167128 - Comess, Kenneth M. ;   et al. | 2004-08-26 |
Sulfonamides having antiangiogenic and anticancer activity App 20040157836 - Comess, Kenneth M. ;   et al. | 2004-08-12 |
Urea kinase inhibitors App 20040034038 - Li, Goaquan ;   et al. | 2004-02-19 |
Farnesyltransferase inhibitors App 20030087940 - Claiborne, Akiyo K. ;   et al. | 2003-05-08 |
Farnesyltransferase inhibitors App 20020115640 - Claiborne, Akiyo K. ;   et al. | 2002-08-22 |